FDA approves historic 'living drug' treatment to fight childhood leukemia

Opening a new era in cancer care, the Food and Drug Administration on Wednesday approved the first treatment that genetically engineers patients' own blood cells into an army of assassins to seek out and destroy childhood leukemia.The CAR-T cell treatment developed by Novartis Pharmaceuticals Corp....
Source: L.A. Times - Health - Category: Consumer Health News Authors: Source Type: news